Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin in Abdominal Surgery Patients
NCT04935814Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jun 2021
- Primary completion
- Aug 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of vasopressin in hypotension, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Variation of cardiac output. Started Jun 2021; status: completed.
02
Drugs
vasopressin
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT04935814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04935814.